Arthur Kuan, CG Oncology CEO
August 2, 2023 08:00 AM EDT
Financing
Startups

CG On­col­o­gy reels in $105M crossover for po­ten­tial late 2024 blad­der can­cer drug fil­ing

Kyle LaHucik

Senior Reporter

CG On­col­o­gy, out to treat blad­der can­cer pa­tients left be­hind by the short­age of Mer­ck’s stan­dard BCG ther­a­py or didn’t ben­e­fit from it in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times